| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |
| mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.05 |
| mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
-0.062 |
0.05 |
| mRNA |
Crizotinib |
FIMM |
pan-cancer |
AAC |
-0.35 |
0.05 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.05 |
| mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.05 |
| mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.06 |
| mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
0.055 |
0.06 |
| mRNA |
GW843682X |
GDSC1000 |
pan-cancer |
AAC |
-0.095 |
0.06 |